Clinical Trials
35 trialsSevAsthma
Assistance Publique - HĂ´pitaux de Paris
Remission in Adults With Severe Asthma in Thailand
Thammasat University
MAPLE-UK
Hvivo
SARP
Milton S. Hershey Medical Center
Swiss Severe Asthma Register
Cantonal Hosptal, Baselland
Treatable Traits of Severe Asthma
Beijing Chao Yang Hospital
Asthma In-Home Monitoring (AIM) Trial
Tripler Army Medical Center
QUANTUM
VitaMed Research LLC
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Sanguine Biosciences
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
CREST
MetroHealth Medical Center
University of Wisconsin Severe Asthma Research Program III
University of Wisconsin, Madison
PrIGMa
Imperial College London
REMOMEPO
Assistance Publique - HĂ´pitaux de Paris
RELIEF-1
Nuvaira, Inc.
FAst
The Cleveland Clinic
BIOAIR
Karolinska Institutet
Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma
Novartis
Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children
Vanderbilt University Medical Center
Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
New York City Health and Hospitals Corporation
Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years
Mundipharma (China) Pharmaceutical Co. Ltd
Eicosanoid Lipids by Airway Cells During Infection With Human Rhinoviruses
University of Wisconsin, Madison
APOLO
Roxall Medicina España S.A
PRODA01
NHS Greater Glasgow and Clyde
Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma
Vaxart
SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)
GlaxoSmithKline
ASMATHERM
Assistance Publique - HĂ´pitaux de Paris
Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
Pearl Therapeutics, Inc.
SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults
GlaxoSmithKline
Risk Factors Associated to Difficult-to-control Asthma
University of Sao Paulo General Hospital
Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder
University of Texas Southwestern Medical Center
EXPRESA
Nantes University Hospital
Gemini Symbicort pMDI
AstraZeneca
NIS-observe Treatment Efficacy in Maintaining Symptoms Control in Moderate/Severe Asthma With Symbicort SMART
AstraZeneca
Effect of Spacer in Extrafine Formoterol-Beclomethasone Treatment to Asthma
Hospital General de Requena